<?xml version="1.0" encoding="UTF-8"?>
<p id="Par36">In combination with curative-intent treatment to the primary tumor and systemic therapy, we hypothesize that an improved local control in the bone genuine de novo synchronous or metachronous oligometastatic disease would be associated with an increased Progression-Free Survival (PFS) and Overall Survival (OS).</p>
